People · Operator
Named in public records as an officer, director or promoter · active 2009–2012 · Biotech / Pharma, Other, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pharmaca Integrative Pharmacy Inc | — | Biotech / Pharma | Series A | $13.6M | $234.5M | 2009 |
| Catterton StriVectin Investment Company, LLC | — | Other | Series A | $12.4M | $186.9M | 2009 |
| City Sports Inc | — | Retailing | Seed | $6.1M | $21.5M | 2011 |
Thomas Stemberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Stemberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Martin Hanaka | 2 | 2 |
| Michael Kennedy | 1 | 10 |
| Richard Willis | 1 | 5 |
| Corey Mulloy | 1 | 5 |
| William Rosenzweig | 1 | 5 |
| RoAnn Costin | 1 | 4 |
| Robert Spellman | 1 | 3 |
| Ted Philip | 1 | 3 |
| Greg Scott | 1 | 3 |
| Joel D. Liffmann | 1 | 3 |
| David Maher | 1 | 2 |
| Richard D. Gersten | 1 | 2 |
| Alan Kessock | 1 | 2 |
| Peter Cornetta | 1 | 2 |
| Jeffrey Connor | 1 | 2 |
| Gregory D. Scott | 1 | 1 |
| Anya Hayden | 1 | 1 |
| Michael Kruteck | 1 | 1 |
| David Delmore | 1 | 1 |
| Mark Panzer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.